Top segments and regional performance

Last year, the company generated ‪48.83 B‬ USD, the most of which — ‪43.77 B‬ USD — came from its top-performing segment, Obesity and Diabetes Care, compared to ‪39.41 B‬ USD the previous year. The greatest contribution came from United States, which accounted for ‪26.19 B‬ USD last year, with ‪24.28 B‬ USD the year before.